logo
Select company
Select metric
$ -0.58EBIT per Share
VS
Market
27
Sector
60
Industry
76
History
100
$ 0.76Close
$ 0.65 - $ 1.48 52-Week Range
Ticker Information

Ticker

XLO

Company Name

XILIO THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XILIO THERAPEUTICS INC - EBIT per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XLO - EBITPS Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT per ShareShare FactorWeighted Average Shares
6/30/2025$ -56.22M$ -0.58196.45M
3/31/2025$ -54.3M$ -0.73174.7M
12/31/2024$ -58.24M$ -1.09153.51M
9/30/2024$ -62.8M$ -0.99163.47M
6/30/2024$ -65.53M$ -1.13157.76M
3/31/2024$ -70.96M$ -2.54127.91M
12/31/2023$ -76.4M$ -2.78127.5M
9/30/2023$ -81.22M$ -2.95127.52M
6/30/2023$ -84.26M$ -3.07127.47M
3/31/2023$ -89.52M$ -3.26127.43M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XILIO THERAPEUTICS INC's latest trailing twelve months (TTM) EBITPS stands at $ -2.07.
  • Over the past 5 years, XILIO THERAPEUTICS INC's average EBITPS has been $ -2.94.
  • The median EBITPS for XILIO THERAPEUTICS INC during this period was $ -2.78
  • XILIO THERAPEUTICS INC reached its highest EBITPS over the past 5 years at $ -0.58.
  • The lowest EBITPS recorded by XILIO THERAPEUTICS INC in the same timeframe $ -13.52

XILIO THERAPEUTICS INC's EBITPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITPS Benchmarks
CompanyEBITPS
BRNS : BARINTHUS BIOTHERAPEUTICS PLC $ -1.72BCAB : BIOATLA INC $ -1.02GBIO : GENERATION BIO CO $ -10.8CRIS : CURIS INC $ -3.08EQ : EQUILLIUM INC $ -0.56VVOS : VIVOS THERAPEUTICS INC $ -1.58VRCA : VERRICA PHARMACEUTICALS INC $ -4.17VERU : VERU INC $ -2.19IRD : OPUS GENETICS INC $ -0.92NEPH : NEPHROS INC $ 0.13

Similar metrics to Shares WA:

Definition of EBIT per Share

[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for XILIO THERAPEUTICS INC is calculated as follows: EBIT [ $ -55.22M ] / (Shares WA [ 26.67M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -2.07 ]

XLO - EBIT per Share, Last 5 years

$ -13.52

Minimum

Dec 31, 2021

$ -0.58

Maximum

Jun 30, 2025

$ -2.94

Average

$ -2.78

Median

EBITPS Benchmark Analysis

 The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.43.
The following table provides additional summary stats:
EBITPS in the Market:
filtered constituents3.79K
min$ -9.72
max$ 10.81
average$ 1.16
median$ 0.39
std$ 3.43